Immediate Impact
26 standout
Citing Papers
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study
2024 Standout
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Works of Melissa Pavilack being referenced
Real-world Treatment Patterns Among Patients with Unresected Stage III Non-Small-Cell Lung Cancer
2019
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melissa Pavilack | 240 | 153 | 47 | 85 | 25 | 319 | |
| Julius Wolf | 186 | 150 | 16 | 83 | 22 | 357 | |
| Vishal Navani | 154 | 192 | 45 | 23 | 38 | 302 | |
| Lidan Yi | 168 | 225 | 18 | 39 | 29 | 329 | |
| Andrew Schmidt | 105 | 120 | 54 | 26 | 28 | 255 | |
| Carla Codecà | 109 | 162 | 33 | 34 | 19 | 353 | |
| Monika Parisi | 107 | 207 | 107 | 40 | 25 | 281 | |
| Luisa Ricaurte | 167 | 97 | 62 | 34 | 25 | 357 | |
| Jennifer M. Suga | 126 | 197 | 60 | 40 | 39 | 327 | |
| Mitchell S. von Itzstein | 96 | 205 | 24 | 43 | 32 | 317 | |
| Silvia Catanese | 98 | 226 | 59 | 27 | 28 | 362 |
All Works
Loading papers...